荧辉医疗
![]()
荧辉医疗是一家专注于改变全球医疗现状的创新企业,专注于生物制药与体外诊断领域。
150-500人 医疗/健康/制药/生物 未融资
荧辉医疗是一家专注于改变全球医疗现状的创新科技企业。有别于医疗健康行业侧重单一业务领域的常规模式,荧辉医疗凭借自身强大的研发实力、跨领域的业务积累、心怀理想的精英团队,打造涵盖生物创新药、医疗器械和诊断产品的整合型医疗健康业务模式,进而以更全方位的思考维度,致力于满足当下中国乃至全球患者的医疗需求。
荧辉将自己定义为前沿科技转化作医疗产品的领跑者,面向全球招募顶尖人才。核心管线横跨再生医学、抗肿瘤、免疫类、代谢综合征、运动医学、泌尿系、血液检测及各类医疗器械等领域,搭建让荧辉人引以为豪的世界一流技术平台,其中干细胞工程实验室、蛋白工程实验室、中药现代化生物工程实验室、微流控芯片工程实验室等正在进行着卓有成效的探索,已有部分产品成功上市。
荧辉医疗得益于十五年的产业积累,自2016年起步入快速发展轨道。身处中国医药发展的黄金时代,作为其中的一份子,我们深感肩上的使命与担当,以拯救生命为己任,以科创兴邦为理想。期待通过不断提供创新诊疗产品,满足更多的临床需求,让荧辉快速成为世界医疗健康领域的领跑者。
Fluotek is an innovative technological company aspiring to reshape the global healthcare landscape. Far from the general pattern of focused market business mode in the healthcare industry, Fluotek endeavors to build integrated healthcare combining the innovative pharmaceuticals, medical device and IVD products by utilizing its strong research and development capability, cross-field resource accumulation and aspiring team of elites. and further meet the healthcare demand in China and around the world with broader perspectives.
Fluotek is defined as a pioneer in transforming cutting-edge technology into diagnostical and treatment products and is looking for exceptional talents globally. Our core pipelines cross multiple fields and cover regenerative medicine, oncology, immunology, metabolism, sports medicine, urology, blood tests and medical devices. We are proud to maintain world technological platforms. Explorations and accomplishments are being proceeded in our stem cell engineering lab, protein engineering lab, and TCM modernization chemical lab, microfluidic chip engineering lab, and multiple products have already launched to the market.
Fluotek is largely aided by its 15-year resource accumulation in the healthcare industry and its recent emergence since 2016. Being part of China’s expansion in healthcare and pharmaceutical industries in its golden age, we realize our importance and missions and prioritize saving lives as our responsibility, and contribute our innovation to the society as our idealization. We are expecting to continuously provide innovative diagnostical and treatment products to fulfill the rising clinical demand, and further grow as the leader of global healthcare.